Caregivers Press For Experimental Alzheimer's Drug

  • Playlist
  • Download
  • Embed
    Embed <iframe src="http://www.npr.org/player/embed/146875971/146875968" width="100%" height="290" frameborder="0" scrolling="no">
  • Transcript

Guest

Jason Karlawish, professor of medical ethics, University of Pennsylvania

A medical study published in Science finds that an FDA-approved skin cancer drug can reduce Alzheimer's-like symptoms in mice. It is unclear if the drug, marketed as Targretin, will have the same effect on humans. Some researchers want to begin testing the drug for its efficacy in treating Alzheimer's patients.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.